Swedish Cancer Society grants SEK 23 million to MedH researchers

We congratulate the six researchers at the Department of Medicine, Huddinge who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2029. Together, the MedH researchers are awarded grants of SEK 23 million.

Petter Höglund , Hematology Unit/HERM.

Title: Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental

studies.

Amount granted for 2025-2027: SEK 3 750 000.

Martin Jädersten , Hematology Unit/HERM.

Title: Targeting SAMHD1 in relapsed/refractory AML: The FLAsH-IV trial.

Amount granted for 2025-2029: SEK 5 000 000.

Isabelle Magalhaes , Hematology Unit/HERM.

Title: Identification of cytotoxic, resilient MSLN CAR T cells for solid tumors treatment.

Amount granted for 2025-2027: SEK 3 000 000.

Karl-Johan Malmberg , Center for Infectious Medicine (CIM).

Title: Off-the-shelf Adaptive NK Cell Therapy Guided by Protein Biologics and Precision Engineering.

Amount granted for 2025-2027: SEK 5 250 000.

Magnus Tobiasson , Hematology Unit/HERM.

Title: Exploring Stem and Immune Cell Dynamics Post- Relapse in Myelodysplastic Syndrome Patients Following Allogeneic Stem Cell Transplantation.

Amount granted for 2025-2027: SEK 3 000 000.

Arnika Wagner , Hematology Unit/HERM.

Title: Identification and Elucidation of druggable targets to increase NK cells functions against Cancer.

Amount granted for 2025-2027: SEK 3 000 000.

/Public Release. View in full here.